Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | sphingosine kinase A B | 0.0369 | 0.5 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0369 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0369 | 0.5 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.0369 | 0.5 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.0369 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0369 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0369 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 20000 nM | Kinase Assay | BINDINGDB. | No reference |
Ki (binding) | = 60000 nM | Kinase Assay | BINDINGDB. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.